Aqr Capital Management LLC Emergent Bio Solutions Inc. Transaction History

Aqr Capital Management LLC

  • $151 Billion
  • Q3 2025

A detailed history of Aqr Capital Management LLC transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 586,246 shares of EBS stock, worth $5.93 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
586,246
Holding current value
$5.93 Million
% of portfolio
0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$5.63 - $9.32 $3.3 Million - $5.46 Million
586,246 New
586,246 $5.17 Million
Q2 2024

Aug 14, 2024
SELL
$1.86 - $6.98 $1.1 Million - $4.13 Million
-591,387 Reduced 56.23%
460,311 $3.14 Million
Q1 2024

May 15, 2024
BUY
$1.5 - $3.41 $807,423 - $1.84 Million
538,282 Added 104.84%
1,051,698 $2.66 Million
Q4 2023

Feb 14, 2024
BUY
$1.82 - $3.16 $608,422 - $1.06 Million
334,298 Added 186.64%
513,416 $1.23 Million
Q3 2023

Nov 14, 2023
BUY
$3.17 - $7.91 $240,942 - $601,215
76,007 Added 73.71%
179,118 $609,000
Q2 2023

Aug 14, 2023
SELL
$7.35 - $13.21 $729,913 - $1.31 Million
-99,308 Reduced 49.06%
103,111 $757,000
Q1 2023

May 15, 2023
SELL
$7.79 - $16.29 $2.7 Million - $5.65 Million
-346,708 Reduced 63.14%
202,419 $2.1 Million
Q4 2022

Feb 14, 2023
BUY
$11.0 - $21.45 $3.28 Million - $6.4 Million
298,253 Added 118.89%
549,127 $6.49 Million
Q3 2022

Nov 14, 2022
BUY
$20.09 - $35.8 $2.74 Million - $4.88 Million
136,235 Added 118.84%
250,874 $5.27 Million
Q2 2022

Aug 15, 2022
BUY
$27.42 - $43.63 $786,624 - $1.25 Million
28,688 Added 33.38%
114,639 $3.48 Million
Q1 2022

May 16, 2022
SELL
$36.48 - $52.22 $14.9 Million - $21.4 Million
-409,549 Reduced 82.65%
85,951 $3.53 Million
Q4 2021

Feb 14, 2022
BUY
$33.11 - $55.01 $4.38 Million - $7.28 Million
132,387 Added 36.46%
495,500 $21.5 Million
Q3 2021

Nov 15, 2021
SELL
$50.07 - $66.05 $15.6 Million - $20.6 Million
-311,166 Reduced 46.15%
363,113 $18.2 Million
Q2 2021

Aug 16, 2021
BUY
$56.61 - $80.46 $17.4 Million - $24.7 Million
307,445 Added 83.81%
674,279 $42.5 Million
Q1 2021

May 17, 2021
BUY
$86.23 - $125.19 $15.9 Million - $23.1 Million
184,746 Added 101.46%
366,834 $33.8 Million
Q4 2020

Feb 16, 2021
BUY
$79.17 - $111.47 $10.2 Million - $14.4 Million
129,074 Added 243.47%
182,088 $16.3 Million
Q3 2020

Nov 16, 2020
SELL
$81.91 - $134.94 $1.71 Million - $2.81 Million
-20,817 Reduced 28.2%
53,014 $5.48 Million
Q2 2020

Aug 17, 2020
BUY
$54.33 - $89.52 $54,655 - $90,057
1,006 Added 1.38%
73,831 $5.84 Million
Q1 2020

May 15, 2020
SELL
$49.34 - $68.76 $1.14 Million - $1.59 Million
-23,128 Reduced 24.1%
72,825 $4.21 Million
Q4 2019

Feb 14, 2020
SELL
$51.21 - $59.06 $1.7 Million - $1.96 Million
-33,113 Reduced 25.66%
95,953 $5.18 Million
Q3 2019

Nov 14, 2019
SELL
$40.6 - $57.2 $2.32 Million - $3.26 Million
-57,026 Reduced 30.64%
129,066 $6.75 Million
Q2 2019

Aug 14, 2019
SELL
$39.92 - $53.86 $2.95 Million - $3.97 Million
-73,800 Reduced 28.4%
186,092 $8.99 Million
Q1 2019

May 14, 2019
SELL
$48.23 - $66.16 $930,067 - $1.28 Million
-19,284 Reduced 6.91%
259,892 $13.1 Million
Q4 2018

Feb 14, 2019
BUY
$55.63 - $73.24 $524,590 - $690,653
9,430 Added 3.5%
279,176 $16.6 Million
Q3 2018

Nov 15, 2018
SELL
$52.05 - $66.51 $374,239 - $478,206
-7,190 Reduced 2.6%
269,746 $17.8 Million
Q2 2018

Aug 14, 2018
SELL
$48.33 - $55.64 $3.02 Million - $3.48 Million
-62,466 Reduced 18.4%
276,936 $14 Million
Q1 2018

May 15, 2018
BUY
$44.44 - $54.39 $218,555 - $267,490
4,918 Added 1.47%
339,402 $17.9 Million
Q4 2017

Feb 14, 2018
BUY
$37.77 - $47.75 $2.57 Million - $3.25 Million
68,050 Added 25.54%
334,484 $15.5 Million
Q3 2017

Nov 14, 2017
BUY
$34.14 - $40.45 $9.1 Million - $10.8 Million
266,434
266,434 $10.8 Million

Others Institutions Holding EBS

# of Institutions
191
Shares Held
41.3M
Call Options Held
899K
Put Options Held
256K
View Full List

About Emergent BioSolutions Inc.

EBS Quotes by TradingView
  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $504M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email